ADVIA CENTAUR® CMV IGG - COFEPRIS Registration 1371R2019 SSA
Access comprehensive regulatory information for ADVIA CENTAUR® CMV IGG (ADVIA CENTAUR® CMV IGG) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1371R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on July 17, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ADVIA CENTAUR® CMV IGG (CMV IGG) PARA LA DETERMINACIÓN CUALITATIVA Y SEMICUANTITATIVA DE ANTICUERPOS IGG FRENTE AL CITOMEGALOVIRUS (CMV) EN SUERO Y PLASMA HUMANO DE SUJETOS PEDIÁTRICOS Y ADULTOS (EDTA DIPOTÁSICO, HEPARINA DE LITIO) CON LOS SISTE
THE ADVIA CENTAUR® CMV IGG (CMV IGG) ASSAY FOR THE QUALITATIVE AND SEMI-QUANTITATIVE DETERMINATION OF IGG ANTIBODIES AGAINST CYTOMEGALOVIRUS (CMV) IN HUMAN SERUM AND PLASMA FROM PAEDIATRIC AND ADULT SUBJECTS (DIPOTASSIUM EDTA, LITHIUM HEPARIN) WITH SYSTEMS